QPS is a GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug development services. Since 1995, it has rapidly expanded from a small bioanalysis shop to a full service CRO with over 1100 employees in the US, Europe, India and Asia Pacific. Today, it offers expanded pharmaceutical contract R&D services with special expertise in Neuropharmacology, DMPK, Toxicology, Bioanalysis, Translational Medicine, and Clinical Development.
Numerous acquisitions have strengthened QPS’ preclinical, early and late phase drug development capabilities worldwide.
Through continual enhancements in capacities and resources, QPS stands tall in its commitment to deliver superior quality, skilled performance and trusted service to its valued customers.